Remdesivir

More than 50% severe coronavirus patients treated with remdesivir recovered, trial reveals

by

More than half of severely ill coronavirus patients treated with Ebola drug remdesivir recovered and were discharged from hospital within two weeks, trial results reveal Gilead Sciences treated 200 severely ill coronavirus patients with its Ebola antiviral remdesivir  Regardless of whether they were treated for five or 10 days, more than half of the patients … Read more

Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients

by

Remdesivir anti-viral trial reports ‘rapid recoveries’ for severe hospitalised coronavirus patients with ‘nearly all’ discharged within a week.    University of Chicago Medicine recruited 125 people with COVID-19 as part of Gilead Science’s clinical trials. Of those people, 113 had severe disease.  All the patients were been treated with daily infusions of remdesivir. Most of them … Read more